These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17697269)

  • 21. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid TLC determination of methadyl acetate and some in vitro metabolites.
    Kochhar MM; Hamrick ME; Bavda LT
    J Pharm Sci; 1976 Jan; 65(1):137-8. PubMed ID: 1255420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic changes in acute opiate withdrawal.
    Stuart Reece A
    QJM; 2009 May; 102(5):357. PubMed ID: 19028746
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhabdomyolysis and brain ischemic stroke in a heroin-dependent male. Invited comment.
    Somala RK
    Acta Psychiatr Scand; 2009 Jul; 120(1):80-1. PubMed ID: 19519677
    [No Abstract]   [Full Text] [Related]  

  • 25. Methadone maintenance treatment of heroin abuse in China.
    Lu L; Zhao D; Bao YP; Shi J
    Am J Drug Alcohol Abuse; 2008; 34(2):127-31. PubMed ID: 18293229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Commentary] modern treatment for prisoners.
    O'Brien CP
    Addiction; 2008 Aug; 103(8):1343. PubMed ID: 18855823
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis supports methadone maintenance efficacy in Scotland.
    Newman R
    Public Health; 2009 May; 123(5):400; author reply 400-1. PubMed ID: 19359024
    [No Abstract]   [Full Text] [Related]  

  • 28. Divided doses for methadone maintenance.
    Adinoff B
    Am J Psychiatry; 2008 Mar; 165(3):303-5. PubMed ID: 18316426
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?
    Gerra G; Maremmani I; Capovani B; Somaini L; Berterame S; Tomas-Rossello J; Saenz E; Busse A; Kleber H
    Subst Use Misuse; 2009; 44(5):663-71. PubMed ID: 19360539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
    Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
    Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explaining the effectiveness of heroin-assisted treatment on crime reductions.
    Löbmann R; Verthein U
    Law Hum Behav; 2009 Feb; 33(1):83-95. PubMed ID: 18594954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts].
    Hao C; Wu JL; Ruan YH; Yao HM; Yang XG; Liu L; Qin GM; Chen KL; Yin L; Song BL; Wang N; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):250-3. PubMed ID: 17959041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.